Your browser is no longer supported. Please, upgrade your browser.
AZN AstraZeneca PLC daily Stock Chart
AstraZeneca PLC
Index- P/E30.83 EPS (ttm)1.20 Insider Own0.50% Shs Outstand2.53B Perf Week0.93%
Market Cap93.28B Forward P/E19.62 EPS next Y1.88 Insider Trans0.00% Shs Float2.53B Perf Month4.90%
Income3.03B PEG1.18 EPS next Q0.33 Inst Own16.60% Short Float0.36% Perf Quarter9.35%
Sales22.47B P/S4.15 EPS this Y-13.40% Inst Trans3.23% Short Ratio2.23 Perf Half Y10.37%
Book/sh5.10 P/B7.22 EPS next Y10.34% ROA4.40% Target Price38.89 Perf Year8.10%
Cash/sh1.53 P/C24.10 EPS next 5Y26.20% ROE20.30% 52W Range28.43 - 37.30 Perf YTD6.17%
Dividend1.40 P/FCF- EPS past 5Y-13.50% ROI13.30% 52W High-1.23% Beta0.63
Dividend %3.80% Quick Ratio0.50 Sales past 5Y-4.30% Gross Margin81.60% 52W Low29.58% ATR0.49
Employees61100 Current Ratio0.70 Sales Q/Q-4.20% Oper. Margin15.40% RSI (14)62.14 Volatility1.62% 1.27%
OptionableYes Debt/Eq1.54 EPS Q/Q-36.70% Profit Margin12.50% Rel Volume1.20 Prev Close37.05
ShortableYes LT Debt/Eq1.21 EarningsMay 18 BMO Payout122.00% Avg Volume4.04M Price36.84
Recom1.80 SMA202.23% SMA503.74% SMA2008.79% Volume4,827,165 Change-0.57%
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-05-17Downgrade UBS Buy → Neutral
Mar-09-17Initiated Liberum Buy
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Sep-12-16Upgrade Jefferies Hold → Buy
May-23-18 05:56PM  Why Big Pharma is finally discovering the Bay Area American City Business Journals
May-22-18 06:03AM  Edited Transcript of AZN.L earnings conference call or presentation 18-May-18 11:00am GMT Thomson Reuters StreetEvents
May-21-18 02:57PM  Stocks Move On Trade Talks As Dow Finds An Unlikely Top Performer In GE Investor's Business Daily
02:45PM  AstraZeneca Gets FDA Nod for Hyperkalaemia Drug Investopedia
12:13PM  U.K. stocks log record close as U.S.-China ease trade-war tensions MarketWatch
11:09AM  AstraZeneca's Lokelma Gains FDA Nod to Treat Hyperkalemia Zacks
06:40AM  AstraZeneca potassium drug finally approved, threatening Vifor Reuters
May-18-18 05:51PM  LOKELMATM Approved in the US for the Treatment of Adults with Hyperkalemia Business Wire
04:22PM  AstraZeneca Blockbuster Is Flailing Will Cancer Drugs Fill The Hole? Investor's Business Daily
03:37PM  Trump talks to Postmaster General about Amazon, plus a retail wrap-up and royal wedding preview Yahoo Finance
02:35PM  Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug Zacks
01:42PM  Astrazeneca PLC (AZN) Q1 2018 Earnings Conference Call Transcript Motley Fool
01:30PM  AstraZeneca pay report rejected by 35 percent of shareholders Reuters
01:21PM  AstraZeneca pay report rejected by 35 percent of shareholders Reuters
12:37PM  U.K. stocks fall from record as AstraZeneca, mining stocks decline MarketWatch
11:56AM  AstraZeneca plc Stock Slips on Q1 Earnings Miss, Falling Crestor Sales InvestorPlace
10:06AM  AstraZeneca's (AZN) Q1 Earnings & Sales Miss, Stock Down Zacks
08:00AM  Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved Benzinga
06:27AM  Italian stocks lead Europe lower as politics spook traders MarketWatch
05:45AM  AstraZeneca insists future is bright after big Crestor sales hit Reuters
05:02AM  Astrazeneca: 1Q Earnings Snapshot Associated Press
02:56AM  [$$] AstraZeneca Profit Slides The Wall Street Journal
01:36AM  [$$] AstraZeneca: appliance of science Financial Times
01:35AM  [$$] AstraZeneca chief Pascal Soriot suffers pay revolt Financial Times
May-17-18 10:24PM  [$$] Stocks to watch: Vodafone, AstraZeneca, Glencore, Campbell Soup Financial Times
09:00AM  Is a Surprise Coming for AstraZeneca (AZN) This Earnings Season? Zacks
May-16-18 06:03AM  3 Dividend Stocks to Fund Your Nest Egg Motley Fool
May-15-18 08:00AM  Free Stock Performance Review on Pfizer and Three More Drug Makers Stocks ACCESSWIRE
May-14-18 12:46PM  The Week Ahead: Coindesk Conference, Walmart And Retailers Close Out Earnings Season Benzinga
11:15AM  How Do Analysts See AstraZeneca PLC (LON:AZN) Performing In The Years Ahead? Simply Wall St.
10:20AM  CEMI: Q1 2018: Product Sales Off To Strong Start, And Should Steepen From Here Zacks Small Cap Research
08:31AM  AstraZeneca's (AZN) Asthma Drug Fasenra Fails in COPD Study Zacks
May-11-18 04:02PM  Why Do 113 Top-Rated Funds Own Shares In This Breakout Cloud Stock? Investor's Business Daily
09:42AM  Pharma Stock Roundup: LLY to Buy Cancer Biotech, J&J, AZN, Roche Announce Updates Zacks
04:31AM  AstraZeneca's Fasenra Fails in Trial of Severe Lung Disease Bloomberg
May-08-18 03:06AM  AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million Reuters
May-07-18 05:07PM  Ionis Pharmaceuticals (IONS) Q1 2018 Earnings Conference Call Transcript Motley Fool
09:06AM  BRIEF-Luye Pharma Group Acquires Astrazeneca's Rights Relating To Seroquel And Seroquel XR Reuters
01:03AM  [$$] AstraZeneca shareholders urged to reject pay report Financial Times
May-01-18 12:51PM  FTSE 100 rises, led by Just Eat, BP, while sterling sinks Reuters
Apr-30-18 10:16AM  PARP Drugs Help Some Breast Cancer Patients, But They're No Magic Bullet Forbes
Apr-26-18 01:50PM  What You Must Know About AstraZeneca PLCs (LON:AZN) ROE Simply Wall St.
Apr-24-18 08:33AM  AstraZeneca raises stake in respiratory partner Circassia Reuters
04:57AM  AstraZeneca flop a fresh blow to cancer immunotherapy combination Reuters
04:57AM  AstraZenecas Lung Cancer Duo Flops Investopedia
02:33AM  AstraZeneca third-line lung cancer combination study fails Reuters
Apr-23-18 11:19AM  FDA Nods to AstraZeneca's Tagrisso for First-Line NSCLC (revised) Zacks
Apr-20-18 10:43AM  Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR Zacks
Apr-19-18 11:49AM  FDA Nods to AstraZeneca's Tagrisso for First-Line NSCLC Zacks
Apr-18-18 08:46PM  AstraZeneca wins U.S. approval for 1st-line use of lung cancer drug Reuters
07:58PM  AstraZeneca wins U.S. FDA approval for 1st-line use of lung cancer drug Reuters
10:35AM  NEWS BITES: Barbara Bush dies at 92, Sessions proposes new limits on opioid production, tax day extended Yahoo Finance Video
Apr-17-18 01:45PM  A new Highmark contract with a pharma company part of a growing trend in drug purchasing American City Business Journals
08:13AM  An Intrinsic Calculation For AstraZeneca PLC (LON:AZN) Shows Its 34% Undervalued Simply Wall St.
Apr-15-18 04:50PM  Updated Overall Survival Data for LYNPARZA® (olaparib) in gBRCA-Mutated HER2-Negative Metastatic Breast Cancer Presented at AACR Business Wire
Apr-11-18 09:36AM  Spectrum Pharma Stock Up on Positive Lung Cancer Study Data Zacks
Apr-10-18 04:14PM  Ionis (IONS) Clinches Licensing Agreement with AstraZeneca Zacks
Apr-09-18 04:39PM  Top Analyst Reports for Microsoft, Merck & Union Pacific Zacks
10:46AM  DAOs and the Potential of Ownerless Business Investopedia
08:19AM  Ionic Pharmaceuticals shares jump 3% premarket on news of license deal with AstraZeneca MarketWatch
07:26AM  Ionis to get up to $300 mln from licensing deal with AstraZeneca Reuters
07:00AM  Ionis and AstraZeneca Advance New Drug for NASH PR Newswire
Apr-06-18 10:11AM  Pharma Stock Roundup: LLY's Cyramza Shines in Cancer Study, PFE & AZN in Focus Zacks
Apr-05-18 09:08AM  3 Emerging Technologies Set to Transform the Pharma World Zacks
07:40AM  Wired News Merck and AstraZeneca Announced that EMA Will Review MAA for LYNPARZA(R) in BRCA-Mutated HER2-Negative Metastatic Breast Cancer ACCESSWIRE
Apr-04-18 08:00PM  Pfizer Has Big Plans in Treating Lung Cancer Motley Fool
10:08AM  AstraZeneca's (AZN) Bydureon Gets FDA Nod for Expanded Use Zacks
Apr-03-18 08:02PM  PRESS DIGEST- Financial Times - April 4 Reuters
08:00AM  US FDA Approves BYDUREON for Use with Basal Insulin in Patients with Type 2 Diabetes with Inadequate Glycemic Control Business Wire
07:00AM  US FDA Accepts Biologics License Application for Moxetumomab Pasudotox in Hairy Cell Leukemia Business Wire
01:00AM  [$$] AstraZeneca receives regulatory boost for oncology drugs Financial Times
Apr-02-18 07:01AM  Compugen, AstraZeneca unit in cancer drug development deal Reuters
Mar-28-18 10:37AM  When Will They Learn? 4 Huge Biotech Blowups Motley Fool
Mar-27-18 08:31PM  Tesaro Wants a Stronger Grip in Ovarian Cancer Motley Fool
07:35AM  Report: Exploring Fundamental Drivers Behind Mobile TeleSystems OJSC, Scorpio Tankers, Magellan Midstream Partners, National Steel, AstraZeneca, and Alibaba Group Holding New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Mar-19-18 04:31PM  Why Amgen Shouldn't Use Its War Chest For A Celgene Megamerger Investor's Business Daily
12:15PM  AstraZeneca Presents New Data Evaluating Safety and Efficacy of FARXIGA in Patients with Type 2 Diabetes and Moderate Renal Impairment Business Wire
Mar-16-18 12:23PM  Why A Biopharma Buying Spree May Target AstraZeneca, Bristol Investor's Business Daily
10:46AM  Pharma Stock Roundup: ABBV's Elagolix Meets Study Goal, MRK's Keytruda in Focus Zacks
Mar-14-18 04:30PM  CEMI: Q4 2017: Strategic Successes and Recent Wins Sets Up 2018 To Be Another Strong Year Zacks Small Cap Research
12:30PM  Is It Time To Buy AstraZeneca PLC (LON:AZN) Based Off Its PE Ratio? Simply Wall St.
Mar-13-18 11:17AM  AstraZeneca's Final Data From Key Lung Cancer Study Delayed Zacks
Mar-12-18 09:08AM  Zacks Industry Outlook Highlights: AstraZeneca, Bayer, Dr. Reddy's Laboratories, Teva Pharmaceuticals and Adamas Pharmaceuticals Zacks
04:36AM  [$$] AstraZeneca faces longer wait on key lung cancer drug test Financial Times
03:49AM  AstraZeneca Delays Final Results of Failed Lung-Cancer Trial Bloomberg
03:38AM  AstraZeneca sees pivotal lung cancer trial results later in 2018 Reuters
Mar-09-18 07:44PM  AstraZeneca Goes Up Against 2 Cancer Upstarts Motley Fool
11:09AM  European Stock Favorites From AstraZeneca To Vodaphone Forbes
07:45AM  Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails Zacks
Mar-08-18 02:29AM  Eisai clinches Merck deal to develop and sell cancer drug, shares soar Reuters
Mar-07-18 06:11PM  Merck, Eisai sign deal to further develop, sell Eisai cancer drug Reuters
04:00PM  Pharmaceutical Industry Outlook - March 2018 Zacks
Mar-06-18 04:57PM  AstraZeneca's Forxiga Label Expansion Filing Accepted in EU Zacks
07:57AM  The Zacks Analyst Blog Highlights: United States Steel, Allegheny, Century, Astrazeneca and Ferrari Zacks
Mar-03-18 08:23AM  AstraZeneca PLC (LON:AZN): Should The Future Outlook Worry You? Simply Wall St.
Mar-01-18 02:34PM  8 Stocks NWQ Managers Continues to Buy
Feb-28-18 08:41PM  [$$] Viela Bio Spins Out From AstraZeneca With Up to $250 Million The Wall Street Journal
04:39PM  Tesaro Dives As Biggest Moneymaker Lags And Another Drug Is Canned Investor's Business Daily
12:13PM  Here's Why Tesaro Inc. Stock Dipped Today Motley Fool
10:55AM  MedImmune announces $250 million spinout, plan to create 100 new jobs American City Business Journals
AstraZeneca PLC discovers, develops, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, gastrointestinal, neuroscience, and infection diseases worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL4, Tenormin5, and Zestril6 for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo4 for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. AstraZeneca PLC serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.